Search Orphan Drug Designations and Approvals
-
Generic Name: | Aripiprazole |
---|---|
Date Designated: | 07/22/2019 |
Orphan Designation: | Treatment of N-glycanase 1 (NGLY1) deficiency |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Perlara PBC 2625 Alcatraz Ave, #435 Berkeley, California 94705 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-